ANKRD35
Ankyrin repeat domain-containing protein 35
Also known as: ANR35_HUMAN, FLJ25124
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N283
- Gene
- ANKRD35
- Ensembl
- ENSG00000198483
- Chromosome
- 1
- Canonical length
- 1001 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Primary cilium,Primary cilium transition zone,Basal body
OverviewNCBI Gene
Predicted to enable actin binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1001 residues, UniProt reviewed canonical sequence.
>Q8N283|ANKRD35
1 MKRIFSCSST QVAVERWNRH DQKLLEAVHR GDVGRVAALA SRKSARPTKL DSNGQSPFHL
61 AASKGLTECL TILLANGADI NSKNEDGSTA LHLATISCQP QCVKVLLQHG ANEDAVDAEN
121 RSPLHWAASS GCASSVLLLC DHEAFLDVLD NDGRTPLMIA SLGGHAAICS QLLQRGARVN
181 VTDKNDKSAL ILACEKGSAE VAELLLSHGA DAGAVDSTGH DALHYALHTQ DKALWRHLQQ
241 ALSRRRRGGQ RLVQHPDLAS QASPSEPQAG SPPKSSWRAE PEEEQEEKED EDPCSEEWRW
301 KYEEERRKVV RLEQELVQKT EECKTQAAAY LDLENQIREQ AQELGVLLSW EPRASGKQGS
361 SLRPGGDGME QGCPKDLLAE STQELKKQQQ AAATVNPVLA PKKAEDSAPG KIQYEVHGRS
421 QPEEQGPPQS PASETIRKAT GQQLTTNGAQ TFGPDHADQL PAGQKESSQV LGVEPGGTVA
481 EPVGPAAMNQ LLLQLREELA AVWREKDAAR GALSRPVMEG ALGTPRAEAA AAAWEKMEAR
541 LERVLARLEW AKAGLQVKPE VPSQESREGA LKAAPGSIKQ DEEKEKRVPG AQGEPLGALG
601 GEKALGGLAK GQLEKEMSVL RLSNSNLLEE LGELGRERQR LQRELQSLSQ RLQREFVPKP
661 QAQVQLQQLR QSVGLLTNEL AMEKEATEKL RKLLASQSSG LRGLWDCLPA DLVGERSAQS
721 KAAESLEELR ACISTLVDRH REAQQVLARL QEENQQLRGS LSPCREPGTS LKAPASPQVA
781 ALEQDLGKLE EELRAVQATM SGKSQEIGKL KQLLYQATEE VAELRAREAA SLRQHEKTRG
841 SLVAQAQAWG QELKALLEKY NTACREVGRL REAVAEERRR SGDLAAQAAE QERQASEMRG
901 RSEQFEKTAE LLKEKMEHLI GACRDKEAKI KELLKKLEQL SEEVLAIRGE NARLALQLQD
961 SQKNHEEIIS TYRNHLLNAA RGYMEHEVYN ILLQILSMEE ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD35 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- skin: 58 nTPM
- esophagus: 24 nTPM
- vagina: 20 nTPM
- cervix: 19 nTPM
- blood vessel: 11 nTPM
- salivary gland: 11 nTPM
Single-cell type
- esophageal apical cells: 113 nCPM
- endometrial ciliated cells: 92 nCPM
- esophageal suprabasal cells: 69 nCPM
- suprabasal keratinocytes: 45 nCPM
- peritubular myoid cells: 41 nCPM
- respiratory secretory cells: 41 nCPM
Immune cell
- classical monocyte: 2.1 nTPM
- memory CD8 T-cell: 1.1 nTPM
- intermediate monocyte: 0.8 nTPM
- gdT-cell: 0.7 nTPM
- naive CD8 T-cell: 0.7 nTPM
- NK-cell: 0.7 nTPM
Brain region
- midbrain: 9.5 nTPM
- thalamus: 8.5 nTPM
- medulla oblongata: 7.7 nTPM
- hypothalamus: 7.6 nTPM
- pons: 7.4 nTPM
- spinal cord: 7.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD35 as an antibody target. Whether an autoantibody or antibody against ANKRD35 could matter depends on whether native ANKRD35 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD35 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANKRD35 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...